This article provides a comprehensive overview of PD‐1/PD‐L1 blockade resistance mechanisms from both primary and acquired resistance perspectives, including tumor intrinsic factors, immune microenvironment components, and systemic factors. Here, PDCD1 is linked to neoplasm.